60 F
New York
Friday, May 7, 2021

MediciNova’s [NASDAQ: MNOV] ibudilast Show Promising Result In Alcohol Use Disorder

Must read

Coinbase Pro Announces it will be Listing Internet Computer’s ICP

Coinbase Pro cryptocurrency exchange has disclosed that it has decided to list ICP once it goes live. ICP is the governance token of the...

WISeKey [NASDAQ: WKEY] Gets Investment to finance its TrustNFT.IO NFT Platform

WISeKey International Holding AG disclosed Friday that it has inked a term-sheet to enter into an unsecured short-term loan and the issuance and...

Moderna [NASDAQ: MRNA] Inks Supply Agreement with Switzerland

Moderna, Inc. disclosed that it has inked a supply agreement on Thursday with the Swiss Federal Government. As per the agreement, Moderna Inc...

TeraBlock Will Have its Own BSCPad IDO Soon

TeraBlock which is a project making a platform for automated cryptocurrency portfolio management disclosed that it is preparing for an initial DEX offering (IDO)...

MediciNova, Inc. [NASDAQ: MNOV] disclosed Thursday the result of the Phase 2 trial evaluating MN-166 (ibudilast) for the treatment of Alcohol Use Disorder (AUD).

Principal Investigator, Lara Ray, Ph.D., Professor at the Department of Psychology, University of California Los Angeles (UCLA) has virtually presented the data at the American Psychological Association.

Ibudilast has shown a positive result in Alcohol Use Disorder. A total of 52 alcohol use disorder patients participated in this trial. The trial is a collaborative effort between MediciNova and Dr. Lara Ray and funded by the Center for Study of Opioid Receptors and Drugs of Abuse.

Shares of MediciNova, Inc. soared 2.08% and up +0.13 during the trading of Thursday. Right now, it has day low range of $6.23 and a day high range of $6.45.

Furthermore, MediciNova had a trading volume of 252.31K as compared to the average volume of 1.60 million. If we look at its profitability, its return on assets (ROA) is -14.90%, return on equity (ROE) is -15.70%.

Turning our focus on liquidity, it has a current ratio of 22.00. Likewise, the quick ratio is the same as the current ratio. Currently, MNOV has a total market capitalization of 298.16 million.

In the past 52-weeks of trading, this company’s stocks have fluctuated between the low of $2.79 and a high of $13.25. It has moved up 129.03% from its 52-weeks low and moved down -51.77% from its 52-weeks high.

Ibudilast has decreased the number of heavy drinking days contrasted to the placebo. Furthermore, Patients who were treated with ibudilast and had attenuated VS activation drank the least in the week after the scan. Moreover, there was a significant effect of ibudilast on alcoholic beverage images (ALC).

More articles

Latest article

Why Chiasma [NASDAQ: CHMA] Stock is Skyrocketed?

Shares of Chiasma, Inc. surged 46.48% during the trading session of Wednesday. Chiasma has disclosed the financial results for the Q1 completed March...

NeoGenomics [NASDAQ: NEO] Announces Acquisition of Inivata Ltd

NeoGenomics, Inc. revealed Wednesday that it has decided to purchase Inivata Ltd. Inivata will grow into a liquid biopsy-centered division together with increasing...

R1 RCM [NASDAQ: RCM] Announces Acquisition of VisitPay

R1 RCM Inc. disclosed Tuesday that it has decided to purchase VisitPay. The firm has inked an agreement to buy VisitPay for nearly...

Binance Coin Makes History as its Market Cap Reach $100 Billion

The market capitalization of Binance set new records as the exchange token of Binance and the native asset of Binance Smart Chain (BSC) touched...

Precipio [NASDAQ: PRPO] Roll Out Rapid COVID-19 Antibody test on Amazon Platform

Shares of Precipio, Inc. skyrocketed 40.35% during the trading session of Monday. The strong performance of the firm has highlighted the positive sentiments...

TechX Ink Deal to Buy Fiat-to-Crypto Merchant Services Gateway XPort Digital

TechX Technologies Inc disclosed Monday that it has bought fiat-to-crypto merchant services gateway XPort digital. The firm has bought a 100% stake in XPort...

Lockheed [NYSE: LMT] Present F-35 Best and Final Offer to Finnish Government

Lockheed Martin Corporation disclosed that it has presented F-35 best and final offer (BAFO) on April 29, 2021, to the Finnish government. It...

Clene [NASDAQ: CLNN] Gets Two Patent Notice of Allowances

Clene Inc. disclosed that Clene Nanomedicine, Inc. U.S. Patent and Trademark Office has provided Notices of Allowance for two significant patent applications. Clene...